Article Sidebar
Views PDF: 94
RESEARCH ON THE PROPORTION AND SOME FACTORS RELATED TO ATRIAL FIBFRILATION IN TYPE 2 DIABETIC PATIENTS AT THE GENERAL HOSPITAL OF BAC LIEU PROVINCE
Main Article Content
Abstract
Introduction: Type 2 diabetes increases the frequency of arrhythmias, the most common of which is atrial fibrillation. A number of studies around the world have determined the rate and factors related to atrial fibrillation in patients with type 2 diabetes, however, there have not been many studies on this issue in Viet Nam. Objectives: Describe the rate and identify some factors related to atrial fibrillation in patients with type 2 diabetes. Meterials and methods: Cross sectional study on 184 patients with type 2 diabetes examined and treated at Bac Lieu General Hospital from April 2023 to March 2024. Results: A total of 184 patients were 47.8% male, mean age was 65.6 ± 10.6 years with mean disease duration of 11.3 ± 4.9 years. The rate of atrial fibrillation was 16.3%, with men accounting for the majority. There were a relationship between gender, alcohol consumption, disease duration over 10 years, HbA1c over 6.5, hypertension and treatment methods with the rate of atrial fibrillation in patients with type 2 diabetes. Ages, DBP, LDL-c and HDL-c were independent factors that impact the onset of atrial fibrillation in patients with type 2 diabetes. Conclusion: The rate of atrial fibrillation in patients with type 2 diabetes is 16.3% and relate to gender, alcohol consumption, duration of diabetes, HbA1c, hypertension and treatment methods.
Article Details
Keywords
Type 2 diabetes, atrial fibrillation, some related factors.
References
2. Fangel M.V et al. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study. Circ Arrhythm Electrophysiol, 2019. 12(5): p. e007030.
3. Seyed Ahmadi et al. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol, 2020. 19(1): p. 9.
4. Matsumoto, C et al. Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care, 2022. 10(2).
5. American Diabetes Association. Standards of medical care in diabetes—2022 abridged for primary care providers. Clinical Diabetes, 2022. 40(1): p. 10-38.
6. Hindricks, G et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European heart journal, 2021. 42(5): p. 373-498.
7. Fatemi, O et al. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). The American journal of cardiology, 2014. 114(8): p. 1217-1222.
8. Đặng Thị Soa, Nguyễn Huy Lợi. Đánh giá sử dụng thuốc trên bệnh nhân rung nhĩ không do bệnh lý van tim điều trị tại Trung tâm tim mạch Bệnh viện Hữu nghị Đa khoa Nghệ An. Tạp chí Y học Việt Nam tập 516 số 1, 2022: tr. 332-337.
9. Trương Bảo Ân. Nghiên cứu kết quả dự phòng đột quỵ bằng thuốc kháng đông đường uống không kháng vitamin K ở bệnh nhân rung nhĩ không do bệnh van tim tại Khoa lão - nội tiết, Bệnh viện Tim mạch An Giang. Bệnh viện Tim mạch An Giang, 2023: tr. 164-177.
10. Tolstrup, J.S et al. Alcohol consumption and risk of atrial fibrillation: Observational and genetic estimates of association. European journal of preventive cardiology, 2016. 23(14): p. 1514-1523.